bacteriophag
lambda
vector
transfer
genom
mammalian
cell
result
express
phageencod
gene
howev
process
ineffici
experi
therefor
conduct
delin
rate
limit
step
involv
use
phage
vector
contain
mammalian
luciferas
report
gene
cassett
effici
phagemedi
gene
transfer
mammalian
cell
quantit
presenc
absenc
pharmacolog
inhibitor
cell
uptak
degrad
pathway
inhibitor
lysosom
proteas
proteasom
inhibitor
strongli
enhanc
phagemedi
luciferas
express
suggest
pathway
contribut
destruct
intracellular
phage
particl
contrast
inhibit
endosom
acidif
effect
phagemedi
gene
transfer
presum
phage
lambda
toler
extend
exposur
low
ph
find
provid
insight
pathway
phage
vector
enter
transduc
mammalian
cell
suggest
may
possibl
pharmacolog
enhanc
effici
phagemedi
gene
transfer
mammalian
cell
final
data
also
suggest
proteasom
complex
may
serv
innat
defens
mechan
restrict
infect
mammalian
cell
divers
viral
agent
bacteriophag
lambda
member
siphovirida
abil
transduc
mammalian
cell
vitro
vivo
eguchi
et
al
geier
merril
lank
et
al
march
clark
jepson
merril
geier
petricciani
zanghi
et
al
howev
process
highli
inefficientpresum
phage
lambda
bacteri
viru
undergon
evolutionari
adapt
necessari
effici
transduct
mammalian
cell
laboratori
interest
use
phage
lambda
novel
gene
transfer
vector
applic
vaccin
gene
deliveri
favor
safeti
profil
compar
mammalian
viru
vector
eas
scalabl
vector
product
previou
studi
shown
lambda
phagemedi
gene
transfer
mammalian
cell
improv
surfac
display
motif
function
receptor
target
nuclear
local
dunn
eguchi
et
al
eguchi
et
al
lank
et
al
zanghi
et
al
zanghi
et
al
find
prompt
us
conduct
experi
identifi
intracellular
pathway
may
rate
limit
lambdamedi
gene
transduct
focus
endocytot
entri
pathway
potenti
role
cellular
degrad
pathway
limit
effici
phagemedi
gene
transfer
mammalian
cell
mani
anim
virus
enter
cell
endolysosom
pathway
adopt
differ
mechan
escap
endosom
lysosom
enter
cellular
cytosol
necessari
travel
nucleu
gene
express
akach
et
al
baer
et
al
blumenth
et
al
chandran
et
al
lakadamyali
rust
zhuang
qiu
et
al
sanchez
schornberg
et
al
superti
et
al
wiethoff
et
al
virus
escap
earli
endosom
funk
et
al
other
requir
acid
environ
late
endosom
lakadamyali
rust
zhuang
wiethoff
et
al
proteas
activ
lysosom
facilit
cytoplasm
entri
andor
uncoat
akach
et
al
baer
et
al
chandran
et
al
mind
use
endosomotrop
drug
includ
omeprazol
chloroquin
examin
role
endosom
phagemedi
gene
transfer
mammalian
cell
experi
addit
pharmacolog
agent
also
perform
determin
whether
lysosom
proteas
host
degrad
machineri
ie
proteasom
might
contribut
ineffici
transduct
mammalian
cell
lambda
phage
vector
studi
reveal
exposur
cell
proteasom
inhibitor
inhibitor
major
lysosom
proteas
cathepsin
b
l
result
strong
enhanc
phagemedi
gene
transfer
thu
proteasom
combin
lysosom
virolog
proteas
may
act
primari
defens
mechan
protect
mammalian
cell
transduct
phage
vector
select
antagon
defens
effici
phagemedi
gene
transfer
significantli
increas
proteasom
play
integr
part
function
cell
regul
protein
degrad
tanaka
chiba
wojcik
demartino
cell
cycl
progress
uddin
et
al
van
kerkhof
strou
receptor
signal
booth
et
al
van
kerkhof
strou
proteasom
also
play
import
role
viru
infect
proteasom
activ
shown
enhanc
effici
infect
sever
virus
includ
minut
viru
mice
mwm
reovirus
chen
et
al
ro
kempf
time
virus
adenoassoci
viru
aav
appear
undergo
ubiquitin
degrad
proteasom
yan
et
al
thu
transgen
express
aav
vector
significantli
enhanc
presenc
proteasom
inhibitor
jen
et
al
yan
et
al
analyz
function
proteasom
phagemedi
gene
transfer
hek
cell
cell
incub
luciferas
encod
phage
particl
presenc
absenc
three
differ
pharmacolog
inhibitor
proteasom
activ
lactacystin
bortezomib
lactacystin
irrevers
inhibitor
bortezomib
revers
inhibitor
complex
experi
use
wildtyp
phage
particl
bear
nativ
lambda
phage
coat
protein
wtgpd
well
modifi
particl
display
pestlik
motif
high
densiti
surfac
tpellgpd
latter
phage
gener
produc
genet
gpddefici
lambda
phage
particl
e
coli
host
cell
express
recombin
deriv
gpd
fuse
truncat
pestlik
motif
deriv
seeligeriolysin
cholesteroldepend
cytolysin
listeria
seeligeri
ito
et
al
ito
et
al
use
previous
describ
method
zanghi
et
al
pest
motif
rich
prolin
p
glutam
acid
aspart
acid
e
serin
threonin
residu
serv
direct
protein
proteasom
degrad
rechstein
roger
therefor
expect
pest
motif
use
experi
rsespaetpesppatpk
design
hereaft
tpell
might
caus
phage
particl
bear
element
becom
target
proteasom
test
predict
compar
gene
transfer
effici
cell
phage
particl
bear
tpellmodifi
gpd
coat
protein
phage
particl
bear
wildtyp
unmodifi
coat
protein
presenc
absenc
pharmacolog
inhibitor
proteasom
result
shown
fig
effici
gene
transfer
phage
particl
bear
either
wildtyp
tpellmodifi
coat
protein
strongli
enhanc
presenc
proteasom
inhibitor
fig
three
proteasom
inhibitor
enhanc
gene
transfer
wild
type
tpell
modifi
particl
hek
cell
show
strongest
effect
phagemedi
luciferas
express
enhanc
fold
similar
trend
observ
cell
treat
lactacystin
bortezomib
data
fig
also
show
cell
roughli
suscept
phagemedi
gene
transfer
co
cell
ii
transduct
tpell
phage
result
approxim
higher
level
luciferas
express
co
cell
compar
wt
phage
fig
latter
result
somewhat
unexpect
light
fact
proteasom
inhibit
led
robust
increas
phagemedi
gene
transfer
therefor
conduct
experi
determin
whether
presenc
intact
pest
motif
fact
necessari
enhanc
phagemedi
gene
transfer
tpell
phage
develop
plasmid
express
construct
encod
major
lambda
phage
coat
protein
gpd
fuse
either
wildtyp
tpell
tpell
mutat
deriv
tpell
two
serin
residu
substitut
alanin
tpellsa
therebi
elimin
pest
element
tpell
gener
luciferaseencod
phage
particl
display
peptid
surfac
use
transduc
cell
analysi
luciferas
express
cell
lysat
reveal
phagemedi
gene
transfer
effici
cell
fact
enhanc
surfac
display
mutat
nonfunct
pest
motif
tpellsa
fig
thu
pest
motif
requir
enhanc
celltransduct
phenotyp
tpell
phage
plan
conduct
followup
studi
identifi
mechanist
basi
enhanc
gene
transfer
effici
tpellbear
phage
determin
whether
tpellbear
phage
mediat
effici
gene
transfer
vivo
compar
wildtyp
phage
context
present
seri
experi
howev
avail
reagent
provid
us
second
luciferaseexpress
phage
use
confirm
result
obtain
wildtyp
phage
particl
also
allow
us
effici
transduc
otherwis
recalcitr
co
cell
next
set
experi
test
whether
proteasom
inhibitor
could
enhanc
phagemedi
gene
transfer
second
fig
proteasom
inhibitor
enhanc
phagemedi
gene
transfer
cell
luciferaseencod
lambda
phage
particl
gener
display
either
wildtyp
major
coat
protein
gpd
wt
recombin
form
gpd
bear
pest
motif
spaetpesppatpk
phage
particl
display
peptid
hereaft
design
tpell
phage
particl
ad
cell
multipl
infect
moi
cell
incub
presenc
proteasom
inhibitor
lactacystin
bortezomib
nm
h
later
cell
wash
cultur
medium
replac
medium
contain
proteasom
inhibitor
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
variou
proteasom
inhibitor
result
increas
phagemedi
luciferas
gene
express
result
achiev
statist
signific
wt
tpell
phage
indic
asterisk
case
one
way
anova
p
valu
b
compar
treat
cell
untreat
control
cell
strong
trend
also
appar
lactacystin
bortezomib
cell
type
select
co
cell
experi
sinc
use
previou
studi
phagemedi
gene
deliveri
eguchi
et
al
co
cell
littl
effect
gene
transfer
effici
bortezomib
lactacystin
enhanc
luciferas
express
fold
fig
differenti
activ
variou
proteasom
inhibitor
versu
co
cell
like
attribut
least
part
fact
proteasom
inhibitor
use
experi
lactacystin
bortezomib
possess
vari
level
inhibitori
activ
differ
six
known
activ
site
proteasom
two
chymotrypsinlik
specif
two
caspaselik
two
trypsinlik
specif
kisselev
goldberg
differ
summar
tabl
may
influenc
activ
proteasom
inhibitor
differ
cell
type
versu
co
cell
well
abil
inhibit
cleavag
specif
proteasom
substrat
kisselev
goldberg
howev
import
note
overal
trend
experi
thu
proteasom
inhibitor
test
enhanc
phagemedi
gene
deliveri
extent
case
degre
achiev
statist
signific
case
degre
inhibit
proteasom
activ
known
prevent
degrad
cellular
protein
exert
strong
effect
activ
cellular
transcript
factor
chauhan
et
al
scheidereit
wullaert
et
al
therefor
perform
control
experi
determin
whether
proteasom
inhibit
might
exert
effect
luciferas
express
nonphag
base
gene
transfer
agent
contain
luciferas
express
cassett
present
genom
lambda
phage
vector
experi
cell
transient
transfect
plasmid
contain
firefli
luciferas
report
gene
transcript
control
human
cmv
major
immediateearli
promot
pcmv
luc
cell
incub
presenc
absenc
bortezomib
prior
harvest
analysi
luciferas
activ
cell
lysat
shown
fig
bortezomib
effect
luciferas
express
pcmv
luc
transfect
cell
strongli
suggest
proteasom
inhibitor
enhanc
gene
transfer
effici
phage
vector
effect
gene
expressionpromot
activ
rather
effect
intracellular
degrad
traffick
phage
particl
ding
et
al
douar
et
al
khor
mcelroy
whittak
yan
et
al
mani
anim
virus
enter
cell
endocyt
pathway
infect
cell
virus
strongli
influenc
endosom
ph
lakadamyali
rust
zhuang
parker
parrish
wiethoff
et
al
investig
role
kisselev
goldberg
b
mammalian
cell
imperm
lactacystin
form
tissu
cultur
media
rapidli
enter
cell
consid
irrevers
inhibitor
proteasom
adduct
slowli
hydrolyz
waterresult
restor
proteasom
activ
c
tppii
tripeptidyl
peptidas
ii
cytosol
proteas
enhanc
gene
transfer
effici
tpell
phage
depend
presenc
function
pest
motif
luciferas
encod
phage
particl
display
either
wildtyp
gpd
protein
wt
tpell
motif
tpell
tpell
motif
contain
mutat
nonfunct
pest
consensu
element
tpellsa
gener
use
transduc
cell
cell
expos
luciferaseencod
phage
particl
moi
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
tpellsa
phage
result
enhanc
effici
phagemedi
luciferas
gene
express
compar
tpell
phage
asterisk
denot
p
b
compar
cell
expos
tpell
phage
determin
two
tail
pair
test
result
wt
phage
figur
deriv
data
shown
data
includ
facilit
comparison
effici
phagemedi
gene
transfer
tpellsa
phage
tpell
phage
unmodifi
wt
phage
fig
proteasom
inhibitor
enhanc
phagemedi
gene
transfer
co
cell
luciferaseencod
lambda
phage
particl
gener
display
either
wildtyp
major
coat
protein
gpd
wt
modifi
form
gpd
tpell
phage
particl
ad
co
cell
moi
cell
incub
presenc
proteasom
inhibitor
lactacystin
bortezomib
nm
describ
legend
fig
h
later
cell
wash
cultur
medium
replac
medium
contain
proteasom
inhibitor
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
variou
proteasom
inhibitor
enhanc
phagemedi
luciferas
gene
express
result
achiev
statist
signific
tpell
phage
indic
asterisk
case
bortezomib
one
way
anova
p
valu
b
compar
bortezomib
treat
cell
untreat
control
cell
strong
trend
also
appar
lactacystin
endosom
acidif
phagemedi
gene
transfer
conduct
initi
experi
use
bafilomycin
specif
inhibitor
vacular
hatpas
shown
fig
bafilomycin
effect
phagemedi
gene
transfer
either
co
cell
confirm
concentr
bafilomycin
use
suffici
rais
endosom
ph
perform
control
experi
fitcdextrantetramethylrhodamin
ad
cell
presenc
absenc
bafilomycin
endosom
ph
assess
flow
cytometri
shown
fig
treatment
cell
nm
bafilomycin
suffici
rais
endosom
ph
thu
lack
effect
bafilomycin
phagemedi
gene
transfer
effici
attribut
failur
agent
inhibit
endosom
acidif
endosomotrop
agent
also
fail
enhanc
phagemedi
gene
transfer
except
high
concentr
chloroquin
confirm
result
obtain
bafilomycin
followup
studi
perform
use
addit
endosomotrop
agent
includ
omeprazol
inhibitor
proton
pump
hkatpas
ii
brefeldin
inhibitor
earlytol
endosom
transit
iii
chloroquin
lysosomotrop
agent
accumul
acid
endosom
increas
endosom
ph
three
endosomotrop
drug
chloroquin
enhanc
phagemedi
gene
transfer
fig
sinc
experi
use
high
dose
chloroquin
respect
co
cell
conduct
followup
analysi
examin
doserespons
effect
associ
chloroquin
treatment
result
studi
fig
show
phagemedi
luciferas
express
significantli
enhanc
cell
incub
high
concentr
chloroquin
lower
concentr
chloroquin
includ
concentr
typic
suffici
prevent
endosom
acidif
modest
nonstatist
signific
effect
phagemedi
gene
transfer
fig
light
data
hypothes
high
concentr
chloroquin
might
enhanc
phagemedi
gene
transfer
mechan
unrel
inhibit
endosom
acidif
one
mechan
inhibit
intracellular
protein
degrad
activ
lysosom
proteas
cathepsin
wibo
pool
bortezomib
enhanc
luciferas
express
plasmid
vector
encod
ident
luciferas
express
cassett
cell
transient
transfect
dna
plasmid
contain
combin
luciferas
report
gene
cmv
promot
present
genom
bacteriophag
construct
cell
transient
transfect
plasmid
dna
use
lipofectamin
maintain
presenc
absenc
bortezomib
nm
h
cell
wash
return
normal
medium
h
follow
addit
plasmid
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
bortezomib
effect
plasmidmedi
luciferas
gene
express
bafilomycin
fail
enhanc
phagemedi
gene
transfer
despit
effect
rais
endosom
ph
co
cell
incub
luciferaseencod
tpell
phage
moi
bafilomycin
ad
cultur
medium
indic
dose
h
later
cell
wash
place
medium
lack
drug
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
bafilomycin
effect
phagemedi
luciferas
gene
express
b
cell
puls
medium
contain
fluorescein
f
tetramethylrhodamin
dextran
presenc
absenc
bafilomycin
h
cell
wash
fresh
media
ad
without
drug
h
later
cell
wash
trypsin
resuspend
fresh
media
flow
cytometr
analysi
f
fluoresc
ratio
ph
sensit
f
ph
insensit
fluoresc
calcul
van
weert
et
al
evalu
whether
inhibitor
cathepsin
b
cathepsin
l
catb
catl
could
promot
phage
gene
transfer
hek
cell
shown
fig
inhibit
either
catb
catl
alon
led
increas
phagemedi
luciferas
express
result
howev
achiev
statist
signific
contrast
simultan
inhibit
cathepsin
led
robust
statist
signific
increas
phagemedi
gene
transfer
observ
consist
hypothesi
lysosom
proteas
target
incom
phage
particl
degrad
therebi
limit
effici
phagemedi
gene
transfer
mammalian
cell
examin
hypothesi
followup
experi
perform
cell
expos
luciferaseencod
phage
fig
endosomotrop
agent
also
fail
enhanc
phagemedi
gene
transfer
except
high
concentr
chloroquin
co
cell
incub
luciferaseencod
tpell
phage
moi
indic
endosomotrop
drug
ad
cultur
medium
dose
omeprazol
ngml
brefeldin
chloroquin
co
cell
respect
h
later
cell
wash
place
medium
lack
endosomotrop
drug
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
omeprazol
brefeldin
effect
phagemedi
luciferas
gene
express
contrast
treatment
cell
high
concentr
chloroquin
result
statist
signific
enhanc
phagemedi
gene
transfer
asterisk
denot
p
b
compar
untreat
cell
determin
oneway
anova
tukey
posttest
b
cell
incub
luciferaseencod
tpell
phage
moi
chloroquin
ad
cultur
medium
indic
dose
h
later
cell
wash
place
medium
lack
drug
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
high
dose
chloroquin
result
statist
signific
enhanc
phagemedi
gene
transfer
asterisk
denot
p
b
compar
untreat
cell
determin
oneway
anova
tukey
posttest
fig
inhibitor
endosom
proteas
enhanc
phagemedi
gene
transfer
cell
incub
luciferaseencod
wt
tpell
phage
moi
indic
drug
ad
cultur
medium
dose
cathepsin
b
inhibitor
catb
cathepsin
l
inhibitor
iii
catl
cathepsin
b
inhibitor
plu
cathepsin
l
inhibitor
iii
respect
catb
l
h
later
cell
wash
place
medium
lack
drug
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
catb
catl
inhibitor
alon
result
modest
increas
phagemedi
luciferas
gene
express
achiev
statist
signific
contrast
treatment
cell
combin
catb
catl
inhibitor
result
statist
signific
enhanc
phagemedi
gene
transfer
asterisk
denot
p
b
compar
untreat
cell
determin
oneway
anova
tukey
posttest
particl
presenc
absenc
lysosom
proteas
inhibitor
either
alon
combin
proteasom
inhibitor
bortezomib
ii
chloroquin
high
concentr
expect
result
inhibit
lysosom
proteas
shown
fig
endosom
proteas
inhibitor
synerg
proteasom
inhibitor
bortezomib
enhanc
phagemedi
luciferas
express
cell
observ
consist
hypothesi
proteasom
inhibitor
endosom
proteas
inhibitor
enhanc
effici
phagemedi
gene
transfer
via
distinct
mechanist
pathway
contrast
exposur
cell
high
concentr
chloroquin
chq
result
strong
statist
signific
increas
phagemedi
luciferas
express
enhanc
cotreat
lysosom
proteas
inhibitor
fig
find
reinforc
hypothesi
chloroquin
enhanc
phagemedi
gene
transfer
princip
via
inhibit
lysosom
proteas
fact
high
dose
chloroquin
exert
much
stronger
effect
phagemedi
gene
transfer
inhibit
two
cathepsin
catb
plu
catl
like
reflect
fact
chq
may
inhibit
lysosom
proteas
addit
catb
catl
confirm
cathepsin
capabl
degrad
phage
particl
phage
capsid
wildtyp
tpell
expos
ng
purifi
cathepsin
l
catl
inactiv
catl
infect
phage
particl
determin
titer
e
coli
host
cell
addit
integr
phage
particl
also
assess
test
whether
phage
genom
dna
remain
resist
exogen
ad
dnase
would
expect
phage
capsid
still
intact
undamag
result
analys
present
fig
fig
show
exposur
catl
result
dosedepend
loss
phage
viabil
high
dose
catl
loss
phage
infect
infecti
titer
wildtyp
phage
particl
fell
pfu
pfu
prepar
expos
high
dose
catl
titer
tpell
phage
fell
pfu
pfu
follow
exposur
high
dose
catl
find
confirm
analysi
dnasesensit
catlexpos
phage
capsid
fig
show
phage
genom
dna
within
catltreat
capsid
exhibit
dosedepend
suscept
degrad
exogen
ad
dnase
wherea
phage
genom
dna
capsid
expos
catl
remain
fulli
resist
dnase
expect
collect
find
provid
direct
evid
catl
capabl
degrad
phage
capsid
understand
better
proteasom
inhibit
might
enhanc
effici
phagemedi
gene
transfer
cell
incub
luciferaseencod
phage
vector
presenc
absenc
bortezomib
subject
acid
wash
remov
residu
surfac
bound
phage
use
prepar
nuclear
dna
extract
phage
genom
dna
within
extract
quantit
dna
pcr
analysi
result
present
fig
normal
term
number
copi
nuclear
phage
dna
per
cell
data
show
exposur
cell
proteasom
inhibitor
result
statist
signific
increas
nuclear
accumul
phage
dna
p
b
fig
inhibitor
endosom
proteas
synerg
proteasom
inhibitor
enhanc
phagemedi
gene
transfer
cell
incub
luciferaseencod
tpell
phage
moi
indic
drug
ad
cultur
medium
dose
cathepsin
b
inhibitor
catb
cathepsin
l
inhibitor
iii
catl
cathepsin
b
inhibitor
plu
cathepsin
l
inhibitor
iii
respect
catb
l
nm
bortezomib
bort
chloroquin
chq
case
indic
cell
also
expos
combin
agent
eg
cabl
bort
chq
bort
h
later
cell
wash
place
medium
lack
drug
h
follow
addit
phage
cell
harvest
lyse
luciferas
activ
measur
exposur
cell
bortezomib
alon
bort
catb
plu
catl
inhibitor
catbl
alon
result
modest
increas
phagemedi
luciferas
gene
express
treatment
cell
combin
agent
catbl
bort
result
synergist
statist
signific
enhanc
phagemedi
gene
transfer
asterisk
denot
p
b
compar
untreat
cell
cell
expos
either
agent
alon
determin
oneway
anova
tukey
posttest
exposur
cell
high
concentr
chloroquin
chq
also
result
strong
statist
signific
increas
phagemedi
gene
transfer
p
b
compar
untreat
cell
oneway
anova
tukey
posttest
howev
cotreat
cell
chq
combin
catb
plu
catl
inhibitor
result
increas
luciferas
express
compar
cell
expos
chq
alon
fig
cathepsin
l
degrad
phage
capsid
vitro
phage
particl
expos
ng
purifi
cathepsin
l
catl
inactiv
catl
infect
wild
type
tpell
phage
particl
determin
titer
e
coli
host
cell
addit
integr
phage
particl
also
assess
ad
dnase
catlexpos
phage
particl
dnase
treatment
phage
particl
lyse
dna
content
collect
subject
agaros
gel
electrophoresi
shown
photograph
ethidium
bromid
etbr
stain
gel
load
dna
extract
equival
amount
indic
phage
follow
exposur
dnase
b
result
show
incub
catl
result
dosedepend
declin
infecti
titer
phage
damag
capsid
result
exposur
phage
genom
dnaand
render
suscept
degrad
dnase
b
panel
b
nt
denot
treatment
catl
mwm
denot
molecular
weight
marker
high
molecular
weight
dna
stain
etbr
repres
intact
linear
phage
genom
dna
approx
kb
length
final
set
experi
evalu
whether
proteasom
inhibitor
enhanc
phagemedi
gene
transfer
level
individu
transduc
cell
increas
level
gene
express
transduc
cell
level
overal
cell
popul
increas
number
transduc
cell
perform
analysi
took
advantag
gfpencod
phage
lysogen
gfp
encod
gfp
report
gene
transcript
control
cmv
promot
present
luc
eguchi
et
al
gfpencod
tpell
phage
ad
cell
presenc
absenc
bortezomib
result
present
fig
data
show
treatment
result
statist
signific
increas
percentag
gfp
posit
cell
versu
control
cultur
mean
fluoresc
intens
mfi
gfp
posit
cell
versu
treatment
cell
bortezomib
also
result
statist
signific
increas
mfi
gfp
express
along
modest
increas
percentag
gfp
posit
cell
achiev
statist
signific
conclud
proteasom
inhibitor
enhanc
phagemedi
gene
transfer
increas
mean
level
gene
express
per
transduc
cell
overal
number
transduc
cell
collect
find
consist
data
suggest
model
proteasom
inhibit
enhanc
phagemedi
gene
transfer
promot
intracellular
surviv
phage
particl
therebi
allow
greater
number
phage
genom
escap
cytoplasm
penetr
nucleu
initi
gene
express
fig
recent
studi
reveal
tail
dsdna
bacteriophag
mammalian
virus
includ
herpesvirus
relat
sever
level
includ
share
featur
capsid
protein
structur
virus
baker
et
al
well
distant
sequenc
homolog
gene
encod
genom
packag
protein
put
terminas
encod
open
read
frame
davison
addit
structur
dna
entri
portal
protein
locat
uniqu
site
capsid
also
conserv
tail
dsdna
bacteriophag
herpesvirus
newcomb
et
al
collect
evolutionari
link
capsid
structur
genom
packag
machineri
provid
compel
evid
two
viral
lineag
share
common
origin
baker
et
al
steven
et
al
interestingli
common
architectur
featur
also
identifi
viru
famili
coulibali
et
al
heldwein
et
al
roch
et
al
interpret
evid
virus
infect
bacteria
anim
share
common
ancestor
bamford
burnett
stuart
benson
et
al
notion
anim
virus
may
trace
ancestri
bacteri
virus
import
evolutionari
implic
lead
question
initi
transfer
virus
bacteria
eukaryot
may
occur
adapt
necessari
order
primordi
bacteri
virus
success
infect
anim
host
studi
lambda
phage
mediat
gene
transduct
mammalian
cell
intend
part
shed
light
question
abil
bacteriophag
lambda
transduc
mammalian
cell
eguchi
et
al
geier
merril
lank
et
al
march
clark
jepson
merril
geier
petricciani
zanghi
et
al
zhong
et
al
also
suggest
bacteriophag
vector
may
util
context
human
vaccin
deliveri
gene
transfer
attract
approach
underscor
fact
bacteriophag
possess
long
histori
safe
human
use
bruttin
brussow
summer
even
immunocompromis
person
bearden
et
al
mego
och
davi
wedgwood
phage
vector
physic
robust
easi
cheap
produc
lack
inher
pathogen
mammalian
host
therefor
perform
seri
fig
exposur
cell
proteasom
inhibitor
result
increas
accumul
phage
dna
cell
incub
luciferaseencod
tpell
phage
moi
presenc
absenc
bortezomib
nm
h
later
cell
wash
place
medium
lack
drug
h
follow
addit
phage
cell
harvest
fraction
lyse
nuclear
phage
dna
level
quantit
dna
pcr
analysi
use
taqman
primerprob
set
specif
lambda
phage
integras
gene
phage
dna
level
normal
measur
level
cellular
dna
rrna
dna
report
copi
lambda
phage
genom
dna
per
cell
analysi
perform
triplic
three
separ
well
cell
result
present
mean
result
bar
repres
standard
error
mean
treatment
cell
bortezomib
result
statist
signific
increas
nuclear
accumul
phage
dna
p
b
compar
untreat
cell
oneway
anova
tukey
posttest
fig
proteasom
inhibitor
enhanc
phagemedi
gene
transfer
increas
mean
level
gene
express
per
transduc
cell
overal
number
transduc
cell
gfpencod
tpell
phage
ad
cell
moi
indic
drug
ad
cultur
medium
dose
nm
bortezomib
bort
h
later
cell
wash
place
medium
lack
drug
h
follow
addit
phage
cell
harvest
gfp
express
measur
flow
cytometr
analysi
analysi
perform
triplic
three
separ
well
cell
result
present
mean
percentag
gfp
posit
cell
mean
fluoresc
intens
mfi
gfp
express
b
bar
repres
standard
error
mean
treatment
cell
result
statist
signific
increas
percentag
gfp
posit
cell
p
b
compar
untreat
cell
oneway
anova
tukey
posttest
mfi
gfp
express
p
b
compar
untreat
cell
oneway
anova
tukey
posttest
treatment
cell
bortezomib
also
result
statist
signific
increas
mfi
gfp
express
p
b
compar
untreat
cell
oneway
anova
tukey
posttest
modest
increas
percentag
gfp
posit
cell
achiev
statist
signific
experi
elucid
ratelimit
step
restrict
effici
bacteriophag
lambdamedi
gene
transfer
mammalian
cell
experi
reveal
inhibit
proteasom
lysosom
proteas
result
effici
phagemedi
gene
transfer
proteasom
also
implic
regul
infect
mani
mammalian
virus
posit
neg
case
minut
viru
mice
mwm
reoviru
proteasom
activ
shown
necessari
effici
viru
infect
target
cell
chen
et
al
ro
burckhardt
kempf
ro
kempf
case
proteasom
activ
found
inhibit
viru
infectiona
exemplifi
human
immunodefici
viru
adenoassoci
viru
aav
douar
et
al
jen
et
al
schwartz
et
al
tang
sambani
sibley
wu
et
al
yan
et
al
fact
proteasom
activ
also
restrict
phagemedi
gene
transfer
suggest
previous
unappreci
similar
postentri
event
regul
cellular
transduct
bacteriophag
vector
mammalian
viral
vector
aav
remain
uncertain
howev
whether
proteasom
inhibit
promot
effici
phagemedi
gene
transfer
interfer
proteasomallymedi
degrad
intracellular
phage
particl
alter
intracellular
traffick
perhap
shunt
late
recycl
endosom
ding
et
al
khor
mcelroy
whittak
studi
necessari
resolv
question
also
conduct
experi
examin
role
lysosom
proteas
regul
mammalian
cell
transduct
lambda
phage
vector
lysosom
proteas
degrad
exogen
protein
enter
cell
endosom
pathway
mego
wibo
pool
might
expect
mediat
destruct
intracellular
virus
fact
howev
mani
anim
virus
success
usurp
enzym
exploit
life
cycl
exampl
includ
aav
coronavirus
includ
caus
agent
sar
filovirus
ebola
viru
reovirus
retrovirus
human
immunodefici
viru
akach
et
al
chandran
et
al
ebert
et
al
golden
et
al
janevalbuena
et
al
moriuchi
moriuchi
fauci
pager
dutch
qiu
et
al
schornberg
et
al
simmon
et
al
virus
reli
lysosom
proteas
facilit
uncoat
andor
activ
viral
fusion
protein
akach
et
al
chandran
et
al
ebert
et
al
golden
et
al
janevalbuena
et
al
moriuchi
moriuchi
fauci
pager
dutch
qiu
et
al
schornberg
et
al
simmon
et
al
contrast
anim
virus
inhibit
lysosom
proteas
cathepsin
b
cathepsin
l
result
effici
cellular
transduct
bacteriophag
lambda
indic
lysosom
proteas
neg
regul
transduct
mammalian
cell
phage
lambda
presum
degrad
intern
phage
particl
unabl
escap
endolysosom
compart
consist
direct
exposur
lambda
phage
capsid
purifi
cathepsin
l
result
signific
decreas
phage
infect
loss
capsid
integr
fig
therefor
interest
note
addit
inhibit
proteasom
complex
also
inhibit
cathepsin
lalond
et
al
possibl
may
contribut
potent
effect
phage
fig
model
lambda
phage
entri
intracellular
transport
mammalian
cell
lambda
phage
particl
like
enter
mammalian
cell
via
nonspecif
macropinocytot
uptak
mechan
lank
et
al
enter
earli
endosom
b
phagecontain
endosom
either
undergo
acidif
fusion
lysosom
result
degrad
phage
particl
lysosom
proteas
c
ii
undergo
lysi
recycl
ding
et
al
result
entri
phage
particl
cytoplasm
e
inhibit
lysosom
proteas
result
stabil
phage
within
lysosom
allow
phage
particl
escap
compart
enter
cytoplasm
denot
dot
arrow
f
major
lambda
phage
particl
within
cytosol
undergo
proteasomallymedi
degrad
g
fraction
particl
success
uncoat
deliv
genom
payload
nucleu
result
express
phageencod
gene
ie
luciferas
report
gene
vector
construct
h
mediat
gene
transfer
fig
hypothesi
lysosom
proteas
degrad
intracellular
lambda
phage
particl
consist
synergist
effect
proteasom
plu
lysosom
proteas
blockad
phagemedi
gene
transfer
fig
suggest
may
possibl
use
pharmacolog
method
significantli
enhanc
effici
phagemedi
gene
express
mammalian
cell
tissu
contrast
proteasom
lysosom
proteas
endosom
acidif
minim
effect
effici
gene
transduct
lambda
phage
vector
sole
endosomotrop
agent
signific
effect
phagemedi
luciferas
express
chloroquin
use
high
concentr
previous
shown
result
inhibit
lysosom
proteas
wibo
pool
presum
endosom
acidif
littl
direct
effect
lambda
phagemedi
gene
transfer
lambda
phage
particl
stabl
resist
prolong
h
exposur
acid
alkali
ph
overal
find
demonstr
proteasom
complex
lysosom
proteas
impos
ratelimit
constraint
effici
lambda
phagemedi
gene
transfer
mammalian
cell
fig
endosom
acidif
exert
effect
process
suggest
proteasom
complex
addit
role
regul
host
cell
protein
turnov
antigen
process
may
also
serv
innat
defens
mechan
restrict
infect
mammalian
cell
divers
viral
agent
capabl
penetr
plasma
membran
includ
prokaryot
virus
bacteriophag
lambda
luc
lysogen
del
ecorisaci
provid
dr
mahito
nakanishi
eguchi
et
al
luc
phage
contain
firefli
luciferas
report
gene
regulatori
control
human
cytomegaloviru
immediateearli
promot
luc
phage
particl
prepar
e
coli
lysogen
stabli
transform
either
plasmid
encod
wildtyp
gpd
plasmid
encod
gpd
fusion
protein
interest
describ
zanghi
et
al
luc
particl
purifi
cscl
densiti
gradient
centrifug
titer
e
coli
cell
zanghi
et
al
human
cell
simian
co
cell
obtain
atcc
cell
cultur
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
mm
lglutamin
phage
transduct
experi
cell
seed
plate
overnight
incub
phage
ad
multipl
infect
moi
presenc
absenc
drug
appropri
h
cell
h
co
cell
thereaft
cell
wash
phosphat
buffer
salin
pb
fresh
drugfre
media
ad
h
addit
phage
cell
wash
pb
lyse
passiv
lysi
buffer
promega
protein
content
lysat
quantit
bradford
assay
equal
amount
lysat
normal
term
protein
content
use
luciferas
assay
luciferas
assay
data
report
rel
light
unit
human
cell
seed
plate
incub
overnight
cell
transfect
ng
mammalian
express
plasmid
encod
luciferas
report
gene
pgwizcmv
luciferas
use
reagent
presenc
absenc
nm
bortezomib
h
thereaft
media
remov
fresh
media
ad
without
bortezomib
cell
incub
addit
h
media
replac
time
without
exogen
drug
h
transfect
cell
wash
pb
incub
passiv
lysi
buffer
promega
lyze
use
two
freezethaw
cycl
protein
content
within
lysat
quantit
use
bradford
assay
equal
amount
lysat
normal
term
protein
content
use
luciferas
assay
luciferas
assay
data
report
rel
light
unit
human
cell
preincub
dmem
medium
fb
overnight
medium
replac
contain
mgml
kd
fluorescein
tetramethylrhodamin
dextran
invitrogen
plu
either
nm
nm
bafilomycin
baf
nigericin
posit
control
drug
neg
control
h
later
cell
wash
warm
pb
fresh
media
ad
without
baf
nigericin
appropri
h
thereaft
cell
wash
warm
pb
detach
trypsin
wash
fresh
media
without
baf
nigericin
appropri
pellet
centrifug
min
g
fluorescein
f
tetramethylrhodamin
fluoresc
quantit
flow
cytometr
analysi
use
fac
calibur
becton
dickinson
standard
curv
gener
suspend
aliquot
cell
presenc
mgml
nigericin
pb
ph
ratio
tf
fluoresc
plot
ph
gener
standard
curv
data
bafilomycintr
nontreat
cell
extrapol
curv
order
calcul
endosom
ph
phage
particl
incub
sm
buffer
presenc
absenc
escal
concentr
cathepsin
l
ng
calbiochem
min
cathepsin
l
heatinactiv
incub
min
heatexposur
effect
stabil
infect
phage
particl
aliquot
sampl
remov
titer
e
coli
host
cell
remain
materi
expos
dnase
assess
capsid
integr
concentr
dnase
buffer
invitrogen
ad
phagecontain
sampl
bring
final
concentr
dnase
buffer
u
dnase
ad
sampl
incub
min
phage
capsid
fulli
partial
degrad
cathepsin
l
phage
genom
dna
digest
treatment
contrast
dna
content
intact
phage
capsid
complet
resist
degrad
dnase
lank
et
al
dnase
proteolyt
inactiv
incub
proteinas
k
mgml
final
concentr
min
digest
also
intend
degrad
phage
capsid
releas
encapsid
phage
dna
extract
phenolchloroform
precipit
ethanol
analyz
electrophoresi
agaros
gel
quantit
analysi
intranuclear
lambda
phage
genom
dna
cell
incub
phage
lambda
moi
presenc
absenc
nm
bortezomib
h
later
media
replac
bortezomibfre
dmem
fb
h
thereaft
cell
wash
cold
pb
nonintern
phage
particl
remov
perform
cold
acid
wash
ch
cooh
nacl
ph
describ
lank
et
al
cell
wash
pb
trypsin
pellet
centrifug
min
g
wash
cold
pb
prior
suspens
lysi
buffer
genom
dna
extract
kit
qiagen
valencia
ca
nuclear
cell
fraction
separ
centrifug
accord
manufactur
instruct
extract
nuclear
lysi
buffer
presenc
proteinas
k
rnase
h
dna
extract
use
genom
dna
extract
kit
qiagen
phage
genom
dna
nuclear
lysat
quantit
dna
qpcr
analysi
biorad
icycl
use
primerprob
set
specif
lambda
phage
integras
gene
probe
tamra
cellular
chromosom
dna
nuclear
lysat
also
quantit
dna
qpcr
analysi
use
primer
probe
set
specif
ribosom
rna
gene
probe
tamra
calcul
copi
number
nuclear
lambda
phage
dna
normal
copi
number
cellular
dna
result
express
number
copi
lambda
phage
dna
per
cell
experi
cell
transduc
gfpencod
phage
gfp
bear
tpellmodifi
capsid
gfp
express
cassett
use
experi
transcript
control
cmv
promot
contain
luc
eguchi
et
al
cell
expos
phage
moi
presenc
absenc
nm
bortezomib
dmem
fb
h
later
media
replac
drugfre
dmem
fb
h
addit
phage
cell
wash
pb
trypsin
pellet
gentl
centrifug
cell
resuspend
dmem
fb
plu
formaldehyd
subject
flow
cytometr
analysi
use
facscalibur
bectondickinson
figur
show
result
repres
least
three
separ
experi
similar
result
except
fig
repeat
twice
data
repres
mean
valu
analys
perform
triplic
unless
otherwis
indic
error
bar
denot
standard
error
mean
statist
signific
taken
p
b
calcul
use
oneway
anova
tukey
post
test
unless
otherwis
indic
